Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma

被引:157
|
作者
Bongarzone, I
Fugazzola, L
Vigneri, P
Mariani, L
Mondellini, P
Pacini, F
Basolo, F
Pinchera, A
Pilotti, S
Pierotti, MA
机构
[1] IST NAZL TUMORI, DIV STAT, I-20133 MILAN, ITALY
[2] IST NAZL TUMORI, DIV ANAT PATHOL & CYTOL, I-20133 MILAN, ITALY
[3] UNIV PISA, INST PATHOL ANAT, PISA, ITALY
来源
关键词
D O I
10.1210/jc.81.5.2006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Oncogenic rearrangements of RET and NTRK1 proto-oncogenes are frequently detected in papillary thyroid carcinomas. Several studies have shown an association between ionizing radiation and development of this tumor type. In addition in vitro irradiation of tumor cell lines induced rearrangements of RET similar to those observed in human papillary thyroid carcinomas. These two observations could be related to the reported increased incidence of papillary thyroid carcinomas in children living in contaminated areas around Chernobyl, given that it has been demonstrated that about 60% of them presents a RET oncogenic activation. However, this high frequency of RET positivity in radiation exposed children does not rule out the possibility that age could also play a role in the development of RET positive tumors. To assess this possibility we looked for a relationship between the presence of RET and NTRK1 oncogenic rearrangements and age at surgery in a sample of 92 consecutive patients. Our results show that, in papillary thyroid carcinoma, the frequency of RET and NTRK1 activation is significantly higher in the group of patients aged 4-30 years, thas supporting the concept that age could be contributing to this thyroid specific carcinogenic process.
引用
收藏
页码:2006 / 2009
页数:4
相关论文
共 50 条
  • [21] Tyrosine kinase receptor alteration of renal vasoconstriction in rats is sex- and age-related
    Passmore, John C.
    Fleming, John T.
    Tyagi, Suresh C.
    Falcone, Jeff C.
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2012, 90 (10) : 1372 - 1379
  • [22] Novel missense, insertion and deletion mutations in the neurotrophic tyrosine kinase receptor type 1 gene (NTRK1) associated with congenital insensitivity to pain with anhidrosis
    Huehne, Kathrin
    Zweier, Christiane
    Raab, Klaus
    Odent, Sylvie
    Bonnaure-Mallet, Martine
    Sixou, Jean-Louis
    Landrieu, Pierre
    Goizet, Cyril
    Sarlangue, Jean
    Baumann, Matthias
    Eggermann, Thomas
    Rauch, Anita
    Ruppert, Sinje
    Stettner, Georg M.
    Rautenstrauss, Bernd
    NEUROMUSCULAR DISORDERS, 2008, 18 (02) : 159 - 166
  • [23] Congenital insensitivity to pain with anhidrosis (CIPA):: effect of TRKA (NTRK1) missense mutations on autophosphorylation of the receptor tyrosine kinase for nerve growth factor
    Mardy, S
    Miura, Y
    Endo, F
    Matsuda, I
    Indo, Y
    HUMAN MOLECULAR GENETICS, 2001, 10 (03) : 179 - 188
  • [24] Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro
    Festuccia, Claudio
    Muzi, Paola
    Gravina, Giovanni Luca
    Millimaggi, Danilo
    Speca, Silvia
    Dolo, Vincenza
    Ricevuto, Enrico
    Vicentini, Carlo
    Bologna, Mauro
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2007, 30 (01) : 193 - 200
  • [25] Novel frameshift and splice site mutations in the neurotrophic tyrosine kinase receptor type 1 gene (NTRK1) associated with hereditary sensory neuropathy type IV
    Verpoorten, N
    Claeys, KG
    Deprez, L
    Jacobs, A
    Van Gerwen, V
    Lagae, L
    Arts, WF
    De Meirleir, L
    Keymolen, K
    Ceuterick-de Groote, C
    De Jonghe, P
    Timmerman, V
    Nelis, E
    NEUROMUSCULAR DISORDERS, 2006, 16 (01) : 19 - 25
  • [26] Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: Roles in specific gene regulation and cellular transformation
    Hwang, JH
    Kim, DW
    Suh, JM
    Kim, H
    Song, JH
    Hwang, ES
    Park, KC
    Chung, HK
    Kim, JM
    Lee, TH
    Yu, DY
    Shong, MH
    MOLECULAR ENDOCRINOLOGY, 2003, 17 (06) : 1155 - 1166
  • [27] No mutation in the TRKA (NTRK1) gene encoding a receptor tyrosine kinase for nerve growth factor in a patient with hereditary sensory and autonomic neuropathy type V
    Toscano, E
    Simonati, A
    Indo, Y
    Andria, G
    ANNALS OF NEUROLOGY, 2002, 52 (02) : 224 - 227
  • [28] Receptor for Activated Protein C Kinase 1 (RACK1) Is Overexpressed in Papillary Thyroid Carcinoma
    Myklebust, Line M.
    Akslen, Lars A.
    Varhaug, Jan Erik
    Lillehaug, Johan R.
    THYROID, 2011, 21 (11) : 1217 - 1225
  • [29] Molecular basis of congenital insensitivity to pain with anhidrosis (CIPA):: Mutations and polymorphisms in TRKA (NTRK1) gene encoding the receptor tyrosine kinase for nerve growth factor
    Indo, Y
    HUMAN MUTATION, 2001, 18 (06) : 462 - 471
  • [30] Lrig1 is an endogenous inhibitor of ret receptor tyrosine kinase activation, downstream signaling, and biological responses to GDNF
    Ledda, Fernanda
    Bieraugel, Oliver
    Fard, Shahrzad Shirazi
    Vilar, Marcal
    Paratcha, Gustavo
    JOURNAL OF NEUROSCIENCE, 2008, 28 (01): : 39 - 49